Latest News February 2020: Dr Olga Gandelman joins the Board of DiagNodus October 2019: Fourth peer-reviewed paper describing preliminary results of the completed CRC study published January 2019: The multicentre clinical study of the use of DiagNodus approach for CRC detection produces impressive results June 2018: Second patent of DiagNodus granted in the US May 2018: Sample collection for the multicentre clinical study of the use of DiagNodus approach for CRC detection successfully completed December 2017: The clinical study of the use of DiagNodus approach for CRC detection made multicentre (Yeovil District Hospital and Southend University Hospital joined the study)

Dr Alexandre Loktionov
Founder, CEO & Scientific Director

Alexandre Loktionov, PhD, is a highly experienced biomedical scientist with over 100 scientific and patent publications.  He has held positions at such renowned scientific organisations as the WHO International Agency for Research on Cancer (IARC, Lyon, France), the German Cancer Research Centre (DKFZ, Heidelberg, Germany) and the UK Medical Research Council (Cambridge, UK). His main direction of research has been molecular pathology, especially investigation of the mechanisms of colorectal disease development. Before founding DiagNodus Alexandre was CSO in two biomedical companies in Cambridge.

Dr Tatiana Bandaletova
Founder, Director & Head of Pathology

Tatiana Bandaletova, PhD,  is an internationally renowned pathologist possessing extensive experience in both clinical and experimental pathology, including immunohistochemistry. Having started her career in the USSR, Tatiana then worked for IARC (Lyon, France), DKFZ (Heidelberg, Germany), MRC (Cambridge, UK) and two biomedical companies in Cambridge. Tatiana's unmatched experience in the cytological analysis of exfoliated colonocytes and free inflammatory cells found in the colorectal mucus makes her a unique expert in this field. She has over 40 scientific and patent publications.

Dr Olga Gandelman
Non-executive Director

Olga Gandelman, PhD, MBA, is an experienced manager, scientist and technologist with a proven track record over 15 years of successful assay development and global commercialisation of novel IBD products. Olga possesses excellent communication and interpersonal skills and ability to develop relationships with multiple stakeholders in both academic and commercial environment.

Mark Donaldson
Financial Advisor

Mark Donaldson is a Chartered Certified Accountant (FCCA) who has significant experience in working with SMEs and early stage businesses. He trained with a local firm of accountants and was a manager at Grant Thornton in East Anglia before leaving to focus on working in a more hands-on role with a small portfolio of companies.